Notes
structured table listing health and non-health consequences of an intervention including those outside the formal healthcare sector; recommended by the Second Panel on Cost-Effectiveness in Health and Medicine
Reference
Kim DD, et al. Perspective and Costing in Cost-Effectiveness Analysis, 1974-2018 PharmacoEconomics : 22 Jul 2020. Available from: URL: https://doi.org/10.1007/s40273-020-00942-2
Rights and permissions
About this article
Cite this article
Perspective and costing important in cost-effectiveness analysis. PharmacoEcon Outcomes News 859, 24 (2020). https://doi.org/10.1007/s40274-020-7033-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7033-9